Ranbaxy, now a subsidiary of Sun Pharmaceuticals, manufactured Tadalafil using robust Good Manufacturing Practices (GMP) compliant processes. These processes adhere to stringent quality control measures at each stage, from raw material sourcing to final product packaging. Verification of raw material identity and purity is crucial; Ranbaxy employed sophisticated analytical techniques like High-Performance Liquid Chromatography (HPLC) and spectroscopy.
Process Validation and Quality Assurance
Rigorous process validation ensured consistent drug product quality. This involved extensive testing throughout the manufacturing process. Parameters like dissolution rate, drug content uniformity, and particle size distribution were meticulously monitored. Quality assurance procedures included regular audits and inspections to maintain compliance with regulatory standards like those set by the US Food and Drug Administration (FDA) and other international agencies. Stability studies, conducted under various environmental conditions, helped determine the shelf life and storage requirements.
Post-Market Surveillance
Post-market surveillance, a key aspect of ensuring continued product safety, involved monitoring adverse events and customer complaints. This data informed continuous improvement efforts and ensured the company’s commitment to patient safety. Ranbaxy’s commitment to quality and regulatory compliance during manufacturing provided patients with confidence regarding the efficacy and safety of their Tadalafil product. Documentation of each step, including detailed batch records, were maintained for complete traceability. This comprehensive approach ensured the consistent production of a high-quality drug.
